117 related articles for article (PubMed ID: 4425853)
1. Effect of clofibrate on blood viscosity in intermittent claudication.
Dormandy JA; Gutteridge JM; Hoare E; Dormandy TL
Br Med J; 1974 Nov; 4(5939):259-62. PubMed ID: 4425853
[TBL] [Abstract][Full Text] [Related]
2. Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Postlethwaite JC; Dormandy JA
Ann Surg; 1975 Jun; 181(6):799-802. PubMed ID: 1138629
[TBL] [Abstract][Full Text] [Related]
3. Haemorheological therapy.
Dormandy J; Postlethwaite J; Goyle K
Bibl Anat; 1977; (16 Pt 2):481-3. PubMed ID: 603589
[No Abstract] [Full Text] [Related]
4. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
5. The importance of plasma fibrinogen in vascular surgery.
Postlethwaite JC
Ann R Coll Surg Engl; 1976 Nov; 58(6):457-64. PubMed ID: 984690
[TBL] [Abstract][Full Text] [Related]
6. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
[TBL] [Abstract][Full Text] [Related]
7. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
[TBL] [Abstract][Full Text] [Related]
8. Blood viscosity of patients with intermittent claudication--concept of "rheological claudication".
Dormandy J; Hoare E; Postlethwaite J
Biorheology; 1976 Jun; 13(3):161-4. PubMed ID: 953251
[No Abstract] [Full Text] [Related]
9. Treatment of severe intermittent claudication by controlled defibrination.
Dormandy JA; Goyle KB; Reid HL
Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.
Dormandy JA; Hoare E; Khattab AH; Arrowsmith DE; Dormandy TL
Br Med J; 1973 Dec; 4(5892):581-3. PubMed ID: 4758518
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease.
Palareti G; Poggi M; Torricelli P; Balestra V; Coccheri S
Thromb Res; 1988 Dec; 52(6):621-9. PubMed ID: 3232130
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
[TBL] [Abstract][Full Text] [Related]
13. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.
Dormandy JA; Hoare E; Colley J; Arrowsmith DE; Dormandy TL
Br Med J; 1973 Dec; 4(5892):576-81. PubMed ID: 4758517
[TBL] [Abstract][Full Text] [Related]
14. Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study.
Fagher B; Persson S; Persson G; Larsson H
Angiology; 1993 Apr; 44(4):300-6. PubMed ID: 8457081
[TBL] [Abstract][Full Text] [Related]
15. [Blood and plasma viscosity versus claudication distance in patients with obliterative atherosclerosis of the lower limbs].
Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S
Pol Arch Med Wewn; 1991 Jan; 85(1):41-9. PubMed ID: 2038575
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of clofibrate therapy in peripheral arteriopathy].
Begg TB; Rifkind BM
Minerva Med; 1971 Sep; 62(72):3469-75. PubMed ID: 5097219
[No Abstract] [Full Text] [Related]
17. Reduction of blood viscosity following plasma exchange.
Kilpatrick D; Fleming J; Clyne C; Thompson GR
Atherosclerosis; 1979 Mar; 32(3):301-6. PubMed ID: 465118
[TBL] [Abstract][Full Text] [Related]
18. [Blood and plasma viscosity and the distance of intermittent claudication in patients with type II diabetes and thrombophlebitis].
Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S; Strugala M
Wiad Lek; 1990 Jun; 43(11):483-8. PubMed ID: 2219912
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
20. The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
Calvert GD; Blight L; Franklin J; Oliver J; Wise P; Gallus AS
Eur J Clin Pharmacol; 1980 May; 17(5):355-62. PubMed ID: 6998709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
